Katherine A. High

Overview

Katherine A. High received an average of $2M in total compensation, including $370K in salary, at Spark Therapeutics from 2014 to 2018.

Source: SEC filings on July 22, 2019, April 20, 2018, and April 21, 2017.

Related executives

We found five more executives who work or worked at Spark Therapeutics.

Jeffrey Marrazzo

Spark Therapeutics

Chief Executive Officer

John Furey

Spark Therapeutics

Chief Operating Officer

Daniel Faga

Spark Therapeutics

Chief Business Officer

Stephen Webster

Spark Therapeutics

Chief Financial Officer

Joseph Barge

Spark Therapeutics

Chief Legal Officer

News

You may also like